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http://dx.doi.org/10.1016/j.kjms.201Abstract During recent decades more than 100,000 new chemicals have been introduced as
common consumer products into our environment. Among these chemicals, endocrine-
disrupting chemicals (EDCs) are of particular concern owing to their toxicity in animal studies
and their impacts on human health. EDCs are ubiquitous in the environment, including the air,
water, and soil. The endocrine-disrupting effect of EDCs has been found to imitate the action
of steroid hormones and promote several endocrine and reproductive disorders in both animal
and human studies. In the present review, we focus on the effects of EDCs on the immune
system. EDCs interfere with the synthesis of cytokines, immunoglobulins, and inflammatory
mediators, and they also affect the activation and survival of immune cells. The dysfunction
of the immune system caused by EDCs may lead to the attenuation of immunity (immunodefi-
ciency) against infection or hyperreactivity of immune responses (allergy and autoimmune
disease). In this review, we summarize epidemiologic, animal, and cell studies to demonstrate
the potential effects of EDCs on immunity, allergy, and autoimmune diseases. We also address
the impact of EDCs on epigenetic regulation.
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Exposure to ubiquitous environmental pollutants, including
chemicals with endocrine-disrupting effects, has increased
in recent years, and the impacts of these pollutants on
human health have been widely explored [1e3]. Endocrine-ed.
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environment and are derived from industrial and agricul-
tural sources, including pesticides, fungicides, insecticides,
herbicides, and other chemicals used in the plastics
industry and in consumer products. EDCs can disrupt the
homeostasis maintained by hormones and result in defects
of neural development and abnormalities of the endocrine
and reproductive systems. The exact molecular mecha-
nisms by which EDCs exert their effect have not been
completely elucidated, but research has suggested that
multiple mechanisms are involved in the action of EDCs [4].
The endocrine-disrupting effect is mediated by imitating or
antagonizing the effect of the steroid hormone through
mechanisms dependent or independent of nuclear recep-
tors, resulting in the transcription of target genes [4,5].
Accordingly, EDCs can interfere with the endocrine system
by influencing hormone synthesis, release, transport,
metabolism and excretion. In addition to affecting the
function of the thyroid and adrenal gland, EDCs may exert
their function as estrogens, antiestrogens, and anti-
androgens, even though the structures of EDCs and sex
hormones are far from similar [6], and could also exert their
function independent of sex hormone-related receptors
[7,8]. Exposure to EDCs is known to be associated with
several diseases involving the endocrine and reproductive
systems [9] and the nervous system [8], and is also associ-
ated with immune dysfunction and inflammation [10].
An interesting observation revealed that the increase in
the prevalence of both autoimmune and allergic diseases
after World War II parallels the increasing usage of plasti-
cizers and the increasing levels of their derivatives as
a form of EDC in the environment [11]. Many EDCs have
been shown to possess immunosuppressive properties, but
they can also increase autoimmune reactions and enhance
inflammation [6,10]. The alteration of the function of the
immune system by EDCs may have two different types of
consequence: one is the reduction in immunity, which
results in immunodeficiency and increased susceptibility to
infectious microorganisms; the other is enhancement of the
immune response, which results in allergic or autoimmune
diseases.Immunomodulatory effects of EDCs
In addition to the endocrine and reproductive systems,
EDCs also markedly affect the immune system. As steroids
and sex hormones are known to play important roles in
regulating immune responses, EDCs may influence immune
responses by various mechanisms. The results from in vitro
and in vivo studies have revealed that EDCs may modulate
the immune system by their action on different levels of
the immune regulatory network, including cellular and
humoral response, survival, maturation, and cytokine
synthesis of immune cells [10]. It is noteworthy that the
biologic effect of EDCs is not as per the traditional toxico-
logic, linear doseeresponse relationship. EDCs, such as
bisphenol A (BPA), or phthalates may stimulate a response
at very low doses, whereas the response is attenuated at
much higher doses, resulting in nonlinear, inverted U-sha-
ped doseeresponse curves [12]. Overall, the modulatory
effects of EDCs on the human immune system can beclassified into three categories: (1) decrease immunity, (2)
induce allergic diseases and inflammation, and (3) induce
autoimmune diseases.Effects of EDCs on immunity
The National Health and Nutrition Examination Survey from
2003 to 2006 revealed that EDCs such as BPA or triclosan
might negatively affect human immune function by
assessing markers of immune function. This study found
that BPA level is negatively associated with the titer of the
anticytomegalovirus antibody in populations under 18 years
of age, suggesting that exposure to EDCs may attenuate
antiviral immunity [13]. In animal studies, EDCs have been
shown to decrease the survival of immune cells. Exposure
to diethylstilbestrol (DES) decreased the numbers of
thymocytes without changing the relative percentages of
the thymocyte subsets [14]. EDCs also modulate cytokine
expression. Interferon (IFN)-g, an important cytokine
against viral invasion, is decreased in concanavalin A-acti-
vated splenocytes isolated from mice treated with genis-
tein or a-zeranol [15,16]. Chemokines, which play
important roles in leukocyte recruitment and inflammation
after invasion of microorganisms, can be modulated by
EDCs. Our previous work revealed that nonylphenol (NP)
and 4-octylphenol (OP) suppressed lipopolysaccharide
(LPS)-induced T helper (Th)1-related chemokine (IFN-g-
inducible protein-10; IP-10) and Th2-related chemokine
(macrophage-derived chemokine; MDC) in human mono-
cytes, suggesting that EDCs may suppress Th1 immunity
against intracellular pathogens and Th2 immunity against
bacterial and parasitic infection [17]. EDCs, such as nitro-
fen and benzyl butyl phthalate, may suppress LPS-induced
activation of macrophages by suppressing tumor necrosis
factor alpha (TNF-a) expression [18]. These results indicate
that EDCs may attenuate immunity against infection.Effects of EDCs on allergic disease and
inflammation
Epidemiologic studies link exposure to EDCs and the
development of allergic diseases. This hypothesis regarding
the association between exposure to EDCs and allergy
deserves to be investigated when taking the rapid and
dramatic increase in the prevalence of allergy over recent
decades in westernized countries into consideration.
Various EDCs act on human beings, from gestational age
through adolescence to old age, and are regarded as
important environmental factors that contribute to the
development and enhancement of chronic inflammatory
diseases, particularly allergic diseases. In fact, in in vitro
and animal studies, many EDCs have been shown to induce
or enhance allergic inflammation.
An epidemiologic survey of an adult population revealed
a potential link between exposure to environmental
pollutants and the occurrence of allergic diseases [19]. A
recent meta-analysis of several epidemiologic studies in
adult populations with or without occupational settings
revealed associations between polyvinyl chloride (PVC)
fumes exposure and the onset of respiratory symptoms
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between EDCs exposure and the development of asthma
and airway diseases in a pediatric population. The
increasing consumption of phthalates in the manufacturing
of PVC materials and other numerous consumer products
has been highly suspected to be associated with the rapid
increase in several chronic inflammatory diseases, including
asthma and allergy in children. In a child cohort study, PVC
flooring in the home was shown to increase the risks of
asthma and allergic rhinitis [21]. Notably, the concentra-
tion of diethyl-hexyl-phthalate in indoor dust is positively
correlated with wheezing at preschool age [22].
One possible mechanism of the effect of EDCs on the
development of allergic diseases is that EDCs may influence
antigen-presenting cells (APCs) and subsequently direct Th2
polarization. For example, EDCs, such as benzophenone, p-
octylphenol, and tributyltin chloride at environmentally
relevant doses, suppress interleukin (IL)-12 and enhance IL-
10 production by splenic antigen-presenting cells (APCs),
and subsequently promote strong Th2 polarization via
suppression of Th1 and augmentation of Th2 development
from naive CD4þ T cells primed with anti-CD3 and the EDCs-
treated splenic APCs [23]. EDCs deplete glutathione levels
in APCs and promote Th2 polarization in mice, leading to
the exacerbation of airway inflammation [24]. Dendritic
cells (DCs) are important targets for EDCs. It is known that
DCs are the primary and potent APCs with a critical role in
the initiation and progression of innate and adaptive
immunity [25,26]. The strategic location of DCs throughout
the peripheral tissues and their role in surveillance for
antigen exposure suggest a likely candidacy as a target cell
type for EDCs. DCs extend dendrites into the lumen to
capture antigen and finally direct T-cell polarization to Th1,
Th2, Treg, or Th17 immune responses [27]. In our previous
study, it was shown that NP and 4-OP may induce TNF-
a production in human peripheral blood myeloid DCs via
epigenetic regulation of the TNFA gene promoter and
promote Th2 polarization of T cells [28]. In addition, airway
bronchial epithelial cells and bronchial smooth muscle cells
are also targets of EDCs. Our previous study indicated that
human bronchial epithelial cells treated with butylbenzyl
phthalate (BBP), bis(2-ethylhexyl) phthalate (BEHP), dibu-
tyl phthalate (DBP), and diethyl phthalate (DEP) increased
bronchial smooth-muscle cell proliferation and migration
by secreting IL-8 and regulated upon activation, normal T-
cell expressed, and secreted (RANTES; CCL5), suggesting
a role of EDCs in asthma airway remodeling [29].
Generally, evidence from animal studies provides
support for an adjuvant effect of EDCs on basic mechanisms
of allergic reaction, including effects on Th2 polarization,
enhancing the expression of Th2 cytokines and increasing
the production of immunoglobulins (IgG1 and IgE) promoted
by the Th2 response [30]. For example, IL-4 production by
hemocyanin- or antigen-primed CD4þ T cells from BPA- and
NP-treated mice [31] or from OP-treated mice [32] is
increased in a concentration-dependent manner. Dieth-
ylhexyl phthalate (DEHP) and di-isononyl phthalate (DINP),
two commonly used plasticizers, enhance IL-4 production in
activated T cells by enhancing the activation of the IL4 gene
promoter in T cells in mice [33]. Enhancement of IgE
production by EDCs has also been found in mice. For
example, DEHP [34] and other phthalates [35] have anadjuvant effect on IgE production. Treatment with BPA, NP,
DEHP, or a reactive metabolite of benzene (hydroquinone)
also increases the levels of antigen-specific IgE in sera of
antigen-sensitized mice [31,33,36]. Taken together, these
findings suggest that EDCs may augment or even shift
immune processes towards an IgE-related response by
enhancing IL-4 production in T cells, supporting the
hypothesis that some EDCs may have the ability to augment
allergic processes.Effects of EDCs on autoimmune disease
Historical trends are consistent with the hypothesis that
environmental chemicalsmay contribute to thedevelopment
of autoimmune diseases because of the simultaneous
increases in theconsumptionofplasticizers and the incidence
of autoimmune diseases such as type 1 diabetes, thyroiditis,
rheumatoid arthritis, and systemic lupus erythematosus [11].
Type 1 diabetes is believed to be an autoimmune-mediated
disease in which the insulin-producing b cells in the
pancreas are destroyed by autoantibodies. The rising inci-
denceof type1diabetes in industrializedcountriesbegan just
after World War II, when widespread use of chemicals began
in these countries [37]. Laboratory evidence suggests that
these chemicalsmay bedirectly harmful to b cells [38] ormay
indirectly make b cells more vulnerable to an autoimmune
attack. It has been shown that infections (e.g., coxsackie
virus infection) are a major risk factor for type 1 diabetes
[39]. EDCsmay potentially interact with infectious organisms
and lead to exacerbation of autoimmunity [40]. In patients
with type 1 diabetes, autoimmune thyroiditis is the most
common comorbidity, andmany chemicals are known thyroid
disruptors [41].
Autoimmune diseases such as systemic lupus eryth-
ematosus and rheumatoid arthritis have a female predom-
inance, and endogenous estrogen is believed to play a role
in modulating immune responses [42]. EDCs may be
sexehormonally active and their effect on the endogenous
pituitaryegonadal axis may suggest their intervention in
the incidence and development of autoimmune diseases. In
a murine animal model, dichloro-diphenyl-trichloroethane
(DDT) exposure markedly increased the incidence of albu-
minuria and reduced uterine weight in lupus-prone mice
but did not affect immunity or mortality [43]. Organo-
chlorine exposure of B/W mice shortens the disease-free
period, suggesting its effect of accelerating the develop-
ment of autoimmune disease [44]. Intriguingly, not all EDCs
are enhancers for the development of autoimmune
diseases. It has been reported that short-term exposure to
BPA suppresses autoimmunity development in B/W mice
through modulation of IFN-g production, inhibition of
albuminuria and elongation of the disease-free period [45].
Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
decreases albuminuria, suppresses serum anti-DNA anti-
body and total IgG levels, and reduces mortality in lupus-
prone mice. TCDD-exposed mice also have lower thymic
and splenic weights, with lower percentages of CD4þCD8þ
thymocytes and splenic CD4þ T cells but a greater
percentage of splenic B220þsIgMþ B cells and a higher
serum IFN-g level, suggesting an immunosuppressive role of
TCDD to murine systemic lupus erythematosus (SLE) [43].
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of autoimmune diseases may result from the affinity for
various types of receptors (e.g., estrogen receptor or aryl
hydrocarbon receptor) and the subsequent intracellular
signaling after the activation of the receptors [46].
Effects of EDCs on epigenetic regulation
Chronic inflammatory diseases such as allergic or autoim-
mune diseases are characterized by overexpression of
multiple inflammatory genes. The expression of genes can
be epigenetically regulated by modification of core histone
or DNA, and can be an important target for therapeutic
applications [47]. Epidemiologic research suggests signifi-
cant environmental effects on diseases. The rapid increase
in chronic diseases over the past several decades cannot be
explained through genetics alone because the genetics in
this period are nearly identical. Environmental EDCs have
been shown to promote the onset and phenotype of
a disease, but seldom do they actually alter the DNA
sequence [48]. Li and colleagues [49] first demonstrated
that exposure to DES in mice during the neonatal period
modulates demethylation in the lactoferrin promoter area,
indicating the modulatory effect of EDCs on epigenetic
change. EDCs have the ability to alter DNA methylation
patterns, and these epigenetic modifications further
interfere with the related gene transcription [48, 50].
Other environmental EDCs including BPA and vinclozolin
also have been shown to have epigenetic effects. Exposure
to BPA at an environmentally relevant dose during the
neonatal developmental period in rats modulates the DNA
methylation pattern and accordingly leads to susceptibility
to prostate carcinogenesis [51]. Maternal exposure to BPA
causes alteration of methylation in the forebrain of fetal
mice [52] and changes the maternal behavior in the female
offspring [53]. BPA can also induce DNA hypomethylation,
which results in loss of normal gene expressions in the
reproductive tract of mice [54]. In addition to the endo-
crine, neural and reproductive systems, our previous
studies have demonstrated the effects of EDCs on epige-
netic changes in the immune system [17,28]. NP and 4-OP
modulate the expression of chemokines via altering
histone H4 acetylation in human monocytes [17], and they
also modulate TNF-a expression via both histone trime-
thylation and acetylation [28]. These results demonstrate
evidence supporting a role of EDCs in modulating the
function of immune cells with the involvement of epige-
netics. EDCs may not only promote the development and
the phenotype of diseases in individuals but also trans-
generationally affect their descendants. The majority of
environmental EDCs do not directly cause genetic muta-
tions or DNA sequence alteration. However, the epigenome
can be changed by EDCs. EDCs may cause epimutations in
the germ line stem cell and allow transgenerational inher-
itance of these epigenetic markers, promoting or acceler-
ating the onset of disease in offspring [55].
Conclusion
Although these in vitro and animal studies suggest possible
mechanisms by which EDCs suppress immunity, enhanceallergic reaction, and modulate autoimmune response, the
results cannot be directly applied to humans. Alteration of
the immune system by environmental EDCs could affect the
ability of individuals to mount well-regulated immune
responses to microbial and vaccine antigens, allergens,
self-antigens, and tumor antigens. In addition to dose, the
timing of chemical exposure is important in relation to the
biologic effects. There are critical windows during early life
in which the immune system is vulnerable to disruption,
and exposure during these periods may increase the risk of
immune system dysfunction later in life. The frequency and
duration of exposure to chemicals, chemical properties,
routine exposure, and interactions with other chemicals as
well as life style factors may also play a role in their bio-
logic effects [56]. The clinical relevance of real-life expo-
sure to EDCs and identification of their molecular targets
still need to be addressed in order to explain the environ-
mentehuman interaction. The lifetime exposures to EDCs
required to induce immunodeficiency, allergy and auto-
immune diseases need to be established, and the lack of in
vivo information in humans needs to be addressed.
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